CEL-SCI (CVM) Insider Trading & Ownership $0.56 0.00 (0.00%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends CEL-SCI (NYSE:CVM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.24%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$80,620.00Number OfInsiders Selling(Last 12 Months)0 Get CVM Insider Trade Alerts Want to know when executives and insiders are buying or selling CEL-SCI stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CVM Insider Buying and Selling by Quarter Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t CEL-SCI Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/8/2024Geert R KerstenCEOBuy30,000$1.39$41,700.00 5/8/2024Patricia B PrichepSVPBuy8,000$1.39$11,120.00 5/8/2024Robert Eugene WatsonDirectorBuy20,000$1.39$27,800.00 (Data available from 1/1/2013 forward) CVM Insider Trading Activity - Frequently Asked Questions Who is on CEL-SCI's Insider Roster? The list of insiders at CEL-SCI includes Geert R Kersten, Patricia B Prichep, and Robert Eugene Watson. Learn more on insiders at CVM. What percentage of CEL-SCI stock is owned by insiders? 16.24% of CEL-SCI stock is owned by insiders. Learn more on CVM's insider holdings. Which CEL-SCI insiders have been buying company stock? The following insiders have purchased CVM shares in the last 24 months: Geert R Kersten ($41,700.00), Patricia B Prichep ($11,120.00), and Robert Eugene Watson ($27,800.00). How much insider buying is happening at CEL-SCI? Insiders have purchased a total of 58,000 CVM shares in the last 24 months for a total of $80,620.00 bought. CEL-SCI Key ExecutivesMr. Geert R. Kersten Esq. (Age 65)Chief Executive & Financial Officer, Treasurer and Director Compensation: $702.79kMs. Patricia B. Prichep (Age 73)Senior VP of Operations & Corporate Secretary Compensation: $295.18kDr. Eyal Talor Ph.D. (Age 68)Chief Scientific Officer Compensation: $351.88kDr. Daniel H. Zimmerman Ph.D. (Age 83)Senior Vice President of Research & Cellular Immunology Compensation: $46.08kMr. John Cipriano (Age 82)Senior Vice President of Regulatory Affairs Compensation: $246.97k More Insider Trading Tools from MarketBeat Related Companies DiaMedica Therapeutics Insider Trading Sagimet Biosciences Insider Trading Skye Bioscience Insider Trading Actuate Therapeutics Insider Trading LifeVantage Insider Trading Scilex Insider Trading Adverum Biotechnologies Insider Trading Ventyx Biosciences Insider Trading Candel Therapeutics Insider Trading Repare Therapeutics Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NYSE:CVM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CEL-SCI Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CEL-SCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
